首页> 外文会议>Society for Biomaterials annual meeting and exposition >Tissue Engineered Human Anterior Cruciate Ligament Derived Cellular Patch for Partial ACL Repair
【24h】

Tissue Engineered Human Anterior Cruciate Ligament Derived Cellular Patch for Partial ACL Repair

机译:组织工程化的人类前交叉韧带衍生的细胞膜片用于部分ACL修复

获取原文

摘要

Our results demonstrate that hACL derived cells can be isolated and expanded, and the PLAGA patch promoted growth. This technique is a reproducible and a reliable way to provide a potential cell source for a wide array of future investigations for ACL reconstruction. Our primary direction with the hACL/2D scaffold is for the future use as a patch to augment primary repair of partial ACL tears. Our protocol would allow a combination of suture repair with a 2D scaffold that offers a delivery system for hACL derived cells into the wound site while simultaneously protecting the cells from the synovial fluid environment. This could allow functional repair and healing of a partial tear, avoiding the comorbidities associated with ACL reconstruction. This technique demonstrates promising results and future investigation will display the potential of this technique for ACL repair and reconstruction.
机译:我们的结果表明,hACL衍生的细胞可以被分离和扩增,而PLAGA贴片可以促进生长。此技术是可重现的可靠方法,可为将来进行ACL重建的广泛研究提供潜在的细胞来源。 hACL / 2D支架的主要方向是将来用作修补剂,以增强对部分ACL泪液的主要修复作用。我们的协议将允许将缝合线修复与2D支架相结合,从而为hACL衍生的细胞向伤口部位提供递送系统,同时保护细胞免受滑液环境的侵害。这样可以进行功能性修复和部分撕裂的愈合,从而避免了与ACL重建相关的合并症。该技术显示出可喜的结果,未来的研究将显示该技术在ACL修复和重建中的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号